Product image of Mannitol Baxter Holding (Mannitol) supplied by GNH India

Mannitol Baxter Holding

Active Ingredient:
Mannitol
Origin:
EU

Mannitol Baxter Holding (Mannitol)

Mannitol, the active ingredient in Mannitol Baxter Holding, is an osmotic diuretic presented as an intravenous solution for intravenous use. It creates an osmotic gradient that helps lower intracranial and intraocular pressure and promotes renal excretion of water and electrolytes in patients with acute kidney injury or during certain surgeries.

GNH India supplies Mannitol Baxter Holding as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Baxter Holding B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mannitol acts as an osmotic diuretic to manage fluid shifts in several clinical situations.

  • Elevated intracranial pressure: reduces brain swelling by drawing water from cerebral tissue into the vascular compartment.
  • Acute renal failure: promotes diuresis to assist renal clearance of waste products.
  • Intraocular pressure elevation: lowers eye pressure in glaucoma or ocular surgery settings.
  • Surgical renal protection: safeguards kidney function during procedures that risk ischemic injury.

How It Works

  • Mannitol exerts its effect by establishing an extracellular osmotic gradient that draws water from intracellular and interstitial spaces into the bloodstream. This increase in plasma osmolarity expands intravascular volume, enhances glomerular filtration, and reduces pressure within the cranial and ocular compartments, thereby facilitating diuresis and pressure relief.

Side Effects

Mannitol may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects

  • Headache: mild to moderate discomfort.
  • Nausea or vomiting: gastrointestinal upset.
  • Electrolyte imbalance: especially hyponatremia or hyperkalemia.
  • Transient hypotension: due to rapid plasma volume expansion.
  • Flank pain: related to increased renal flow.
  • Thirst or dry mouth.

Serious or Rare Side Effects

  • Acute renal failure: paradoxical worsening of kidney function.
  • Pulmonary edema: fluid overload in susceptible patients.
  • Severe electrolyte disturbances: leading to cardiac arrhythmias.
  • Hemolysis: in patients with G6PD deficiency.
  • Allergic reactions: rash, urticaria, or anaphylaxis.
  • Metabolic acidosis: from excessive acid load.

Precautions & Warnings

Mannitol should be used with careful clinical monitoring.

  • Renal function assessment: avoid in patients with established renal failure unless benefits outweigh risks.
  • Fluid balance monitoring: watch for signs of overload or dehydration.
  • Electrolyte surveillance: correct abnormalities before and during therapy.
  • Cardiovascular status: use cautiously in patients with heart failure or unstable hemodynamics.
  • Pregnancy and lactation: safety not established; weigh potential benefits against unknown risks.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Mannitol can interact with several medications, requiring vigilance.

Major Interactions (Avoid)

  • Loop diuretics (e.g., furosemide): may exacerbate electrolyte loss and volume depletion.
  • Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of renal injury.
  • Insulin or oral hypoglycemics: osmotic shifts may affect glucose control.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: additive blood pressure lowering effects.
  • Anticoagulants: altered plasma volume may affect drug concentrations.
  • CNS depressants: enhanced sedation if intracranial pressure changes rapidly.

Frequently Asked Questions

Mannitol Baxter Holding is an intravenous osmotic diuretic used to lower elevated intracranial or intraocular pressure, promote diuresis in acute renal failure, and protect renal function during certain surgical procedures. It works by drawing water from tissues into the bloodstream, facilitating fluid removal.

Mannitol creates an osmotic gradient in the extracellular fluid, pulling water from cells and interstitial spaces into the vascular compartment. This increase in plasma osmolarity expands intravascular volume, enhances glomerular filtration, and reduces pressure in the brain and eyes, aiding fluid clearance.

The dose of Mannitol Baxter Holding is determined by the prescribing clinician based on the patient’s condition, weight, and response. Healthcare professionals calculate the appropriate infusion rate and total volume to achieve the desired therapeutic effect while monitoring safety parameters.

Safety data for Mannitol in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use is only considered when the potential benefit justifies any possible risk to the fetus or infant, and it should be discussed with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Mannitol is a non‑metabolizable sugar alcohol that provides rapid osmotic diuresis, whereas alternatives like hypertonic saline may have different electrolyte profiles and slower onset. Mannitol’s high osmolarity makes it effective for quick pressure reduction, but careful monitoring of fluid and electrolytes is essential.

Mannitol Baxter Holding should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from light, moisture, and extreme temperature fluctuations. Do not freeze or shake the container before use.

Mannitol Baxter Holding is administered intravenously by a qualified healthcare professional. The solution is infused over a controlled period, typically using an infusion pump, with dosage adjusted according to clinical response and monitored parameters such as urine output and electrolyte levels.

Serious risks include acute renal failure, pulmonary edema from fluid overload, severe electrolyte disturbances that can cause cardiac arrhythmias, hemolysis in G6PD‑deficient patients, and rare allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these occur.

Mannitol is contraindicated in patients with established anuric renal failure, severe dehydration, active intracranial hemorrhage where rapid volume expansion is harmful, and those with known hypersensitivity to mannitol. Caution is also advised for patients with heart failure or uncontrolled electrolyte imbalances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.